Industry Updates for the Psychedelics World

Psychedelics News

Industry

Breaking News, Industry

12 Apr 2022

Breaking News: Numinus Wellness to Acquire Novamind

We’ve been expecting this to happen in one way or another....

By Jason Najum

Industry

6 Apr 2022

Going Mainstream: Psychedelic Water Signs Deal w Urban Outfitters

De-stigmatization is a major part of getting psychedelics through the gauntlet of cultural and legislative hurdles, so getting a product with the word “psychedelic” on shelves and into the hipster...

By Jason Najum

Industry

5 Apr 2022

Field Trip Granted Patent for Lead Compound FT-104

Today they continued to deliver on their projected milestones with the announcement that the patent has been formally granted and gives exclusive rights to Field Trip....

By Jason Najum

Industry

5 Apr 2022

Stifel Initiates (Positive) Coverage on Awakn Life Sciences

Investment firm Stifel GMP has initiated coverage on Awakn and their prognostication is pretty positive....

By Jason Najum

Join Our Newsletter for Exclusive Updates, Stories, and More

Industry

25 Mar 2022

A Closer Look at Clearmind Medicine

With dozens of companies racing to drive classic psychedelics through clinical trials, or spending years and untold millions developing next-generation versions of these well-known molecules, Clearmind could have its own...

By Jason Najum

Industry

24 Mar 2022

Mydecine Receives IRB Approval for Phase 2b Smoking Trial

Today the company reported the IRB (Institutional Review Board) has approved its Phase 2b study, paving the way for the next major step (FDA approval of its IND or Investigational...

By Jason Najum

Industry

23 Mar 2022

Filament Health Granted Second Patent

Filament has developed innovative technology to extract and standardize stable doses of natural compounds from magic mushrooms....

By Microdose

Industry

23 Mar 2022

Heading to Phase 3? PharmaTher Announces Positive Results for Ketamine Trial

If a Phase 3 study is actually in their near future, then PharmaTher would further solidify itself as a serious top tier firm and official king of Ketamine....

By Jason Najum

Industry

18 Mar 2022

A Closer Look at MindBio Therapeutics

So while ATAI and MindMed draw more eyeballs and investors to the sector, smaller firms like MindBio have the chance to do their early work while the wider industry grows...

By Microdose

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result